BRCA2 and cancer: A predicted splicing alteration in the tumor suppressor gene BRCA2 and a R294C mutation in centrobin, a centrosomal BRCA2 interacting protein were detected, which may have contributed to cancer progression in this model (Additional file 7: Table S5).